cotinine drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (9)
Papers in which this entity is mentioned.
- Infant subcortical brain volumes associated with maternal obesity and diabetes: a large multicohort human study. (2026)
- Prenatal alcohol exposure alters brain structure and neurocognitive outcomes for 6- to 7-year-old children in a South African birth cohort. (2025)
- Prenatal alcohol exposure and white matter microstructural changes across the first 6-7 years of life: A longitudinal diffusion tensor imaging study of a South African birth cohort. (2024)
- A global multicohort study to map subcortical brain development and cognition in infancy and early childhood. (2024)
- Prenatal depression exposure alters white matter integrity and neurodevelopment in early childhood. (2022)
- Embryonic Nicotine Exposure Disrupts Adult Social Behavior and Craniofacial Development in Zebrafish. (2022)
- Central white matter integrity alterations in 2-3-year-old children following prenatal alcohol exposure. (2021)
- Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study. (2019)
- Risk and protective factors for child development: An observational South African birth cohort. (2019)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cotinine | drug | 46 | 253 |
| plasma cotinine | drug | 1 | 4 |
| serum cotinine | drug | 1 | 1 |
| urinary cotinine | drug | 1 | 1 |
| circulating cotinine level | drug | — | — |
| nicotine metabolite | drug | — | — |